Shanghai Nianxing Industrial Co., Ltd
China
Product Name: Barecetamab (anti-ERBB3)
Price:
Purity: 95.0%
Stocking Period: 10 Day
Contact: Yang

2275727-74-5

2275727-74-5 structure

2275727-74-5 structure

Name: Barecetamab
Chemical Name: Barecetamab
CAS Number: 2275727-74-5
Molecular Formula:
Molecular Weight:
Catalog: Signaling Pathways JAK/STAT Signaling EGFR
Create Date: 2023-01-15 18:46:49
Modify Date: 2024-04-08 22:14:16
Barecetamab (ISU-104) is a fully human anti-ErbB3 monoclonal antibody. Barecetamab can be used for the research of recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)[1].

Name	Barecetamab

Description	Barecetamab (ISU-104) is a fully human anti-ErbB3 monoclonal antibody. Barecetamab can be used for the research of recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> JAK/STAT Signaling >> EGFR Signaling Pathways >> Protein Tyrosine Kinase/RTK >> EGFR
In Vitro	Barecetamab (ISU-104) 是一种人源话抗 ErbB3 单克隆抗体。Barecetamab 可用于复发/转移性 (R/M) 头颈部鳞状细胞癌 (HNSCC) 的研究。
References	[1]. Kim SB, et, al. 887P Final results and biomarker analysis from a phase I dose-expansion (part II) study of ISU104 (barecetamab; a novel anti-ErbB3) monotherapy or in combination with cetuximab (CET), in patients (pts) with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC). VOLUME 32, SUPPLEMENT 5, S797, SEPTEMBER 01, 2021.

No Any Chemical & Physical Properties